Viewing Study NCT04928261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-01-31 @ 11:24 PM
Study NCT ID: NCT04928261
Status: RECRUITING
Last Update Posted: 2025-06-25
First Post: 2021-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Sponsor: Ottawa Hospital Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cardiac toxicities View
None Her2 Positive View
None Pathological complete response View